Causes, Frequency and Management Wegovy (semaglutide 2.4 mg) can cause headaches as a recognised adverse effect in some patients
In a 10-week, once-daily, multiple-dose trial, 84 healthy males received 20 or 40 mg oral semaglutide (with 300 mg SNAC), placebo, or placebo with SNAC, and 23 males with type 2 diabetes (T2D) received 40 mg oral semaglutide (with 300 mg SNAC), placebo, or placebo with SNAC
Some pharmacies also offer 1 mg/mL, 2 mg/mL, or 10 mg/mL formulations
This can significantly reduce the desire to eat between meals, supporting sustained weight loss efforts
In Study 6, the proportions of patients who discontinued study drug were 7.9%, 6.5%, and 3.0% for WEGOVY 1.7 mg, WEGOVY 2.4 mg, and placebo, respectively
Symptoms include severe abdominal pain, nausea, and vomiting